Characterization of a short isoform of the kidney protein podocin in human kidney
Authors:
- Linus A VölkerLVLinus A Völker
- Eva-Maria SchurekESEva-Maria Schurek
- Markus M RinschenMRMarkus M Rinschen
- Judit TaxJTJudit Tax
- Barbara A SchutteBSBarbara A Schutte
- Tobias LamkemeyerTLTobias Lamkemeyer
- Denise UngrueDUDenise Ungrue
- Bernhard SchermerBernhard Schermer
- Thomas BenzingTBThomas Benzing
- Martin HöhneMHMartin Höhne
Open Access
- 6 May 2013
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 102-8
Abstract
Background Steroid resistant nephrotic syndrome is a severe hereditary disease often caused by mutations in the NPHS2 gene. This gene encodes the lipid binding protein podocin which localizes to the slit diaphragm of podocytes and is essential for the maintenance of an intact glomerular filtration barrier. Podocin is a hairpin-like membrane-associated protein that multimerizes to recruit lipids of the plasma membrane. Recent evidence suggested that podocin may exist in a canonical, well-studied large isoform and an ill-defined short isoform. Conclusive proof of the presence of this new podocin protein in the human system is still lacking. Methods We used database analyses to identify organisms for which an alternative splice variant has been annotated. Mass spectrometry was employed to prove the presence of the shorter isoform of podocin in human kidney lysates. Immunofluorescence, sucrose density gradient fractionation and PNGase-F assays were used to characterize this short isoform of human podocin. Results Mass spectrometry revealed the existence of the short isoform of human podocin on protein level. We cloned the coding sequence from a human kidney cDNA library and showed that the expressed short variant was retained in the endoplasmic reticulum while still associating with detergent-resistant membrane fractions in sucrose gradient density centrifugation. The protein is partially N-glycosylated which implies the presence of a transmembranous form of the short isoform. Conclusions A second isoform of human podocin is expressed in the kidney. This isoform lacks part of the PHB domain. It can be detected on protein level. Distinct subcellular localization suggests a physiological role for this isoform which may be different from the well-studied canonical variant. Possibly, the short isoform influences lipid and protein composition of the slit diaphragm complex by sequestration of lipid and protein interactors into the endoplasmic reticulum.Keywords
This publication has 18 references indexed in Scilit:
- New perspectives on the renal slit diaphragm protein podocinLaboratory Investigation, 2011
- Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor–dependent signaling pathways in renal collecting duct cellsProceedings of the National Academy of Sciences, 2010
- Isolation and Enrichment of Glomeruli Using Sieving Techniques2009
- A single conserved proline residue determines the membrane topology of stomatinBiochemical Journal, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007
- Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channelsProceedings of the National Academy of Sciences, 2006
- Automated Quantification Tool for High-Throughput Proteomics Using Stable Isotope Labeling and LC−MSnAnalytical Chemistry, 2006
- Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient MiceMolecular and Cellular Biology, 2004
- Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrinJournal of Clinical Investigation, 2001